Skip to main content

INDICAID COVID-19 Rapid Antigen Test Authorized for Use in Japan

Press Release

August 4, 2023

INDICAID COVID-19 Rapid Antigen Test Authorized for Use in Japan

INDICAID COVID-19 Rapid Antigen Test Approved for Use in Japan

PHASE Scientific announces that its INDICAID COVID-19 Rapid Antigen Test has received approval from the Ministry of Health, Labour and Welfare (MHLW) of Japan. This authorisation allows the test to be used in Japan for the identification of SARS-CoV-2.

 

Learn more about our INDICAID COVID-19 Rapid Antigen Test at indicaid.com

 

 

 

 

 

 

 

 

More Related News